Angle are listen on AIM and are a world leading liquid biopsy company. ANGLE plc
is a commercially driven medical diagnostic company specialising in the development of
pioneering products in cancer diagnostics.
ANGLE’s Parsortix® system has the potential to deliver profound improvements in clinical and health economic outcomes in the treatment and diagnosis of cancer.
They are awaiting FDA clearance for their Parsortix® system for metastatic breast cancer.